VEZF Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of VEZF Antibodies for research focused on understanding vascular endothelial zinc finger protein (VEZF). VEZF Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VEZF plays a crucial role in regulating gene expression related to vascular development and endothelial cell function. The significance of VEZF in angiogenesis and vascular biology makes it an important target for studies related to cardiovascular diseases and tumor progression. Understanding VEZF mechanisms can provide insights into therapeutic strategies for various conditions. Researchers worldwide utilize VEZF monoclonal antibodies to advance their studies in vascular development. Current investigations focus on how VEZF influences endothelial cell behavior and blood vessel formation. Ongoing research explores VEZF's potential as a therapeutic target in treating vascular disorders. Santa Cruz Biotechnology monoclonal antibodies for VEZF research continue to support scientific discoveries that advance our understanding of vascular biology and disease treatment.